Hospital admissions and exercise capacity decline in patients with COPD

European Respiratory Journal

Volumn 43, Issue 4, 2014, Pages 1018-1027

  Ramon, Maria A ^a,b,c   Gimeno Santos, Elena ^d,e   Ferrer, Jaume ^a   Balcells, Eva ^f,g   Rodríguez, Esther ^a,h   De Batlle, Jordi ^b,c   Gómez, Federico P ^d,i,j   Sauleda, Jaume ^k   Ferrer, Antoni ^c,f,g,h,l   Barberà, Joan A ^c,m   Agustí, Alvar ^c   Gea, Joaquim ^c,f,g,h,n   Rodriguez Roisin, Robert ^c,m   Antó, Josep M ^d,e,f,g   Garcia Aymerich, Judith ^d,e,g  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^e CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^f INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^g UNIVERSITAT POMPEU FABRA   (Spain)

^h HOSPITAL DEL MAR   (Spain)

ⁱ INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^j INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^k HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^l HOSPITAL DE SABADELL   (Spain)

^m UNIVERSITY OF BARCELONA   (Spain)

ⁿ Fundació Investigació Sanitaria Illes Balears FISIB   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HOSPITAL ADMISSION; HUMAN; LENGTH OF STAY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ANTHROPOMETRY; EXERCISE; HEALTH STATUS; HOSPITALIZATION; MIDDLE AGED; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STATISTICAL MODEL;

AGED; ANTHROPOMETRY; EXERCISE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HOSPITALIZATION; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PATIENT ADMISSION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84897470067     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00088313     Document Type: Conference Paper

References (32)

1. Vestbo J, Hurd SS, Agusti A.G., et al Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187: 347-365.
2. Barnes PJ, Celli BR Systemic manifestations and comorbidities of COPD. Eur Respir J 2009; 33: 1165-1185.
3. Pitta F, Troosters T, Spruit M.A., et al Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171: 972-977.
4. Kessler R, Faller M, Fourgaut G., et al Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159: 158-164.
5. Oga T, Nishimura K, Tsukino M., et al Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med 2003; 167: 544-549.
6. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-117.
7. Spruit MA, Polkey MI, Celli B, et al Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease. J Am Med Dir Assoc 2012; 13: 291-297.
8. Pinto-Plata V.M., Cote C, Cabral H., et al The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 2004; 23: 28-33.
9. Oga T, Nishimura K, Tsukino M., et al Exercise capacity deterioration in patients with COPD: longitudinal evaluation over 5 years. Chest 2005; 128: 62-69.
10. Miravitlles M, Ferrer M, Pont A., et al Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax 2004; 59: 387-395.
11. Garcia-Aymerich J., Serra PI, Mannino D.M., et al Lung function impairment, COPD hospitalisations and subsequent mortality. Thorax 2011; 66: 585-590.
12. Spruit MA, Gosselink R, Troosters T., et al Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax 2003; 58: 752-756.
13. Brower RG. Consequences of bed rest. Crit Care Med 2009; 37: S422-S428.
14. Pitta F, Troosters T, Probst V.S., et al Physical activity and hospitalization for exacerbation of COPD. Chest 2006; 129: 536-544.
15. Puhan MA, Gimeno-Santos E, Scharplatz M., et al Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2011; 10: CD005305.
16. Garcia-Aymerich J., Gomez FP, Anto JM Phenotypic characterization and course of chronic obstructive pulmonary disease in the PAC-COPD Study: design and methods. Arch Bronconeumol 2009; 45: 4-11.
17. Garcia-Aymerich J., Gomez FP, Benet M, et al Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax 2011; 66: 430-437.
18. Celli BR, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946.
19. Puhan MA, Mador MJ, Held U, et al Interpretation of treatment changes in 6-minute walk distance in patients with COPD. Eur Respir J 2008; 32: 637-643.
20. Polkey MI, Spruit MA, Edwards L.D., et al Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization. Am J Respir Crit Care Med 2013; 187: 382-386.
21. Donders AR, van der Heijden GJ, Stijnen T, et al. A gentle introduction to imputation of missing values. J Clin Epidemiol 2006; 59: 1087-1091.
22. Puhan MA, Chandra D, Mosenifar Z., et al The minimal important difference of exercise tests in severe COPD. Eur Respir J 2011; 37: 784-790.
23. Bu XN, Yang T, Thompson M.A., et al Changes in the BODE index, exacerbation duration and hospitalisation in a cohort of COPD patients. Singapore Med J 2011; 52: 894-900.
24. Celli BR, Barnes PJ Exacerbations of chronic obstructive pulmonary disease. Eur Respir J 2007; 29: 1224-1238.
25. Lucas AR, Korol R, Pepine CJ Inflammation in atherosclerosis: some thoughts about acute coronary syndromes. Circulation 2006; 113: e728-e732.
26. Decramer M, Lacquet LM, Fagard R, et al Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am J Respir Crit Care Med 1994; 150: 11-16.
27. Bestall JC, Paul EA, Garrod R, et al Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 581-586.
28. Nishimura K, Izumi T, Tsukino M., et al Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121: 1434-1440.
29. Goldstein RS, Hill K, Brooks D., et al Pulmonary rehabilitation: a review of the recent literature. Chest 2012; 142: 738-749.
30. Vestbo J, Edwards LD, Scanlon P.D., et al Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med 2011; 365: 1184-1192.
31. Laupacis A, Wells G, Richardson W.S., et al Users' guides to the medical literature. V. How to use an article about prognosis. Evidence-Based Medicine Working Group. JAMA 1994; 272: 234-237.
32. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996; 153: 976-980.